A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection

Canadian Respiratory Journal

Volumn 10, Issue 7, 2003, Pages 381-388

  Marra, Fawziah ^a   Marra, Carlo A ^a   Stiver, H Grant ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Amantadine; Influenza; Prophylaxis; Rimantadine

Indexed keywords

AMANTADINE; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; PLACEBO; RIMANTADINE;

AGITATION; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BLOOD TOXICITY; CANADA; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; COGNITIVE DEFECT; CONCENTRATION LOSS; CONFIDENCE INTERVAL; DELIRIUM; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MARKETING; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EMBASE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEADACHE; HUMAN; IMPOTENCE; INFLUENZA VIRUS A; INSOMNIA; LIVER TOXICITY; MEDLINE; META ANALYSIS; NEPHROTOXICITY; NERVOUSNESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMOTOR DISORDER; RASH; RISK ASSESSMENT; SEIZURE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VERTIGO;

EID: 0344444289     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/453183     Document Type: Article

References (48)

1. Influenza in Canada: 1998-1999 season. Can Commun Dis Rep 1999;25:1-54.
2. Noble GR. Epidemiological and clinical aspects of influenza. In: Beare AS, ed. Basic and Applied Influenza Research. Boca Raton: CRC Press, 1982:11-50.
3. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48:1-28.
4. Monto AS, Kioumehr F. The Tecumseh study of respiratory illness. IX. Occurrence of influenza in the community, 1966-1971. Am J Epidemiol 1975;102:553-63.
5. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med 1978;298:587-92.
6. Murphy BR, Webster RG. Orthomyxoviruses. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology, 3rd edn. Philadelphia: Lippincott-Raven Publishers, 1996;1397-445.
7. Barker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health 1986;76:761-5.
8. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980;112:798-811.
9. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982;4:25-44.
10. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. Ann Intern Med 1995;123:518-27.
11. Couch RB, Keitel WA, Cate TR. Improvement of inactivated influenza virus vaccines. J Infect Dis 1997;176(Suppl 1):S38-44.
12. Aoki FY. Amantadine and rimantadine. In: Nicolson KG, Webster RG and Hay AJ, eds. Textbook of Influenza. Oxford: Blackwell Science, 1998:457-76.
13. Douglas RG Jr. Drug therapy: Prophylaxis and treatment of influenza. N Engl J Med 1990;322:443-50.
14. Dersimonian, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986:7:177-88.
15. Cook DJ, Sackett DL, Spitzer DL. Methodologic guidelines for systematic reviews of randomized controlled trials in health care from the Potsdam consultation on meta-analysis. J Clin Epidemiol 1995;48:167-71.
16. Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials 1986;7:267-75.
17. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988;7:889-94.
18. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. Br Med J 1994;309:1351-5.
19. Rosenthal R. Meta-analysis: A review. Psychosom Med 1991;53:247-71.
20. Oker-Blom N, Hovi T, Leinikki E et al. Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: A controlled field trial. BMJ 1970;3:676-8.
21. Monto AS, Gunn RA, Bandyk MG, et al. Prevention of Russian influenza by amantadine. JAMA 1979;241:1003-7.
22. Kantor RJ, Potts DW, Stevens D, et al. Prevention of influenza A/USSR/77 (H1N1): An evaluation of the side effects and efficacy of amantadine in recruits at Fort Sam Houston. Mil Med 1980;145:312-5.
23. Pettersson RF, Hellstrom PE, Penttinen K, et al. Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: A controlled field trial among young adults and high-risk patients. J Infect Dis 1980;142:377-83.
24. Reuman PD, Bernstein DI, Keefer MC, et al. Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antiviral Res 1989;11:27-40.
25. Brady MT, Sears SD, Pacini DL, et al. Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic. Antimicrob Agents Chemother 1990;34:1633-6.
26. Quarles JM, Couch RB, Cate TR, et al. Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza. Antiviral Res 1981;1:149-55.
27. Dolin R, Reichman RC, Madore HF, et al. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982;307:580-4.
28. Muldoon RL, Stanley ED, Jackson GG. Use and withdrawal of amantadine chemoprophylaxis during epidemic influenza A. Am Rev Respir Dis 1976;113:487-91.
29. Plesnik V, Heinz F, Bindas B, et al. Controlled study of influenza prophylaxis by VUFB amantadine. Cesk Epidemiol Mikrobiol Imunol 1977;26:216-26.
30. O'Donoghue JM, Ray CG, Terry DW Jr, et al. Prevention of nosocomial influenza infection by amantadine. Am J Epidemiol 1973;97:276-82.
31. Payler DK, Purdham PA. Influenza A prophylaxis with amantadine in a boarding school. Lancet 1984;i:502-4.
32. Atkinson WL, Arden NH, Patriarca PA, et al. Amantadine prophylaxis during an institutional outbreak of type A (H1N1) influenza. Arch Intern Med 1986;146:1751-6.
33. Arden NH, Patriarca PA, Fasano MB, et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 1988;148:865-8.
34. Galbraith AW, Oxford JS, Schild GC, et al. Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment. Lancet 1969;ii:1026-8.
35. Wendel HA, Snyder MT, Pell S. Trial of amantadine in epidemic influenza. Clin Pharmacol Ther 1966;7:38-43.
36. Smorodintsev AA, Karpuhin GI, Zlydnikov DM, et al. The prophylactic effectiveness of amantadine hydrochloride in an epidemic of Hong Kong influenza in Leningrad in 1969. Bull World Health Organ 1970;42:865-72.
37. Hayden FG, Gwaltney JM Jr, Van de Castle RL, et al. Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults. Antimicrob Agents Chemother 1981;19:226-33.
38. Callmander E, Hellgren L. Amandatine hydrochloride as a prophylactic in respiratory infections. A double-blind investigation of its clinical use and serology. J Clin Pharmacol 1968;8:186-9.
39. Schapira M, Oxford JS, Galbraith AW. A study of 1-adamantamine hydrochloride during the 1970 Hong Kong influenza epidemic. J R Coll Gen Pract 1971;21:695-7.
40. Stiver HG, Graves F, Eickhoff TC, Meiklejohn G. Efficacy of "Hong Kong" vaccine in preventing "England" variant influenza in 1972. N Engl J Med 1973;289:1267-71.
41. Hayden FG, Hoffman HE, Spyker DA. Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics. Antimicrob Agents Chemother 1983;23:458-64.
42. Hayden FG, Gwaltney JM Jr, Van de Castle RL, et al. Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults. Antimicrob Agents Chemother 1981;19:226-33.
43. Guay DRP. Amantadine and rimantadine prophylaxis of influenza A in nursing homes: A tolerability perspective. Drugs Aging 1994;5:8-19.
44. Jefferson T, Demichelli V, Deeks J, et al. Amantadine and rimantadine for preventing and treating influenza A in adults. Cochrane Database Syst Rev 2002;3:1-54.
45. Stern JM, Simes RJ. Publication bias: Evidence of delayed publication in a cohort study of clinical research projects. Br Med J 1997:315:640-5.
46. Tramer MR, Reynolds DJM, Moore RA, McQuay HJ. Impact of covert duplicate publication on meta-analysis: A case study. Br Med J 1997;315:635-40.
47. Keyser LA, Nafziger KM, Bertino JS Jr. Comparison of central nervous system side effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients. Arch Intern Med 2000;22:1485-8.
48. Dumyati G, Falsey AR. Antivirals for influenza: What is their role in the older patient? Drugs Aging 2002;19:777-86.